$HSIC News

Henry Schein Announces Leadership Transitions

Piper Sandler Maintains Overweight on Henry Schein, Raises Price Target to $95

Q1 Earnings Roundup: Henry Schein (NASDAQ:HSIC) And The Rest Of The Dental Equipment & Technology Segment

UBS Maintains Neutral on Henry Schein, Raises Price Target to $89

Are Investors Undervaluing Henry Schein (HSIC) Right Now?

Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus

Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET

Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report?

What to Expect From Henry Schein's Next Quarterly Earnings Report

BMO Capital Initiates Coverage On Henry Schein with Market Perform Rating, Announces Price Target of $85

Is Henry Schein (HSIC) Stock Undervalued Right Now?

GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide

3 Reasons to Avoid HSIC and 1 Stock to Buy Instead

Is Henry Schein Stock Underperforming the Nasdaq?

Henry Schein: Smile Because The Upside Isn't Over

How Investors Are Reacting To Henry Schein (HSIC) Upgrade On Dental Strength And Margin Improvements

BTIG Upgrades Henry Schein to Buy, Announces $100 Price Target

Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026

Is This the Right Time to Keep HSIC Stock in Your Portfolio?

Henry Schein, Inc. (HSIC) Presents at Stifel Jaws & Paws Conference 2026 Transcript